During the past decade, Municipal Oncology Centre of Uzhgorod Central Municipal Clinical Hospitlal conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 5 clinical trials were completed, i.e. on average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Municipal Oncology Centre of Uzhgorod Central Municipal Clinical Hospitlal" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "BeyondSpring Pharmaceuticals Inc." with 2 trials sponsored, "Peregrine Pharmaceuticals" with 2 trials sponsored and "Axelar AB" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Municipal Oncology Centre of Uzhgorod Central Municipal Clinical Hospitlal" #1 collaborator was "Academic GI Cancer Consortium (AGICC)" with 1 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Municipal Oncology Centre of Uzhgorod Central Municipal Clinical Hospitlal" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Chemotherapy-induced Neutropenia" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Non-Squamous Non-Small Cell Lung Cancer" (2 trials) and "Non-small-cell Lung Cancer" (2 trials). Many other conditions were trialed in "Municipal Oncology Centre of Uzhgorod Central Municipal Clinical Hospitlal" in a lesser frequency.

Most popular intervention types in "Municipal Oncology Centre of Uzhgorod Central Municipal Clinical Hospitlal" are "Drug" (21 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Atezolizumab" (3 trials), "Paclitaxel" (3 trials), "Amivantamab" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Municipal Oncology Centre of Uzhgorod Central Municipal Clinical Hospitlal" are 19 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Municipal Oncology Centre of Uzhgorod Central Municipal Clinical Hospitlal". undefined are not yet recruiting, 2 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Municipal Oncology Centre of Uzhgorod Central Municipal Clinical Hospitlal, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Municipal Oncology Centre of Uzhgorod Central Municipal Clinical Hospitlal, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".